Marshall Wace, LLP 111, Inc. Transaction History

Marshall Wace, LLP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.64 - $3.41 $374,352 - $483,538	-141,800 Reduced 85.76%	23,536 $62,000
Q4 2022 Feb 14, 2023	SELL	$2.39 - $3.71 $87,156 - $135,292	-36,467 Reduced 18.07%	165,336 $499,000
Q3 2022 Nov 14, 2022	SELL	$2.1 - $3.35 $14,620 - $23,322	-6,962 Reduced 3.33%	201,803 $539,000
Q2 2022 Aug 15, 2022	BUY	$1.42 - $2.89 $26,864 - $54,675	18,919 Added 9.97%	208,765 $429,000
Q1 2022 May 16, 2022	BUY	$1.69 - $3.5 $91,873 - $190,270	54,363 Added 40.13%	189,846 $505,000
Q4 2021 Feb 14, 2022	BUY	$3.12 - $6.11 $422,706 - $827,801	135,483 New	135,483 $473,000

320K

14.6K

4.9K

Ticker YI
Exchange NASDAQ
Sector Healthcare
Industry Pharmaceutical Retailers
Shares Outstandng 83,271,600
Market Cap $54.1M
Description
111, Inc. operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultati...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.